QQ客服 官方微博 反馈留言

	Economic Evaluation of First-Line Treatments for Metastatic Renal Cell Carcinoma: A Cost-Effectiveness Analysis in A Health Resource-Limited Setting
	Wu, Bin; Dong, Baijun; Xu, Yuejuan; Zhang, Qiang; Shen, Jinfang; Chen, Huafeng; Xue, Wei
刊名	PLOS ONE
	2012
卷号	7期号:3
ISSN号	1932-6203
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3673587
专题	上海中医药大学
推荐引用方式 GB/T 7714	Wu, Bin,Dong, Baijun,Xu, Yuejuan,et al. Economic Evaluation of First-Line Treatments for Metastatic Renal Cell Carcinoma: A Cost-Effectiveness Analysis in A Health Resource-Limited Setting[J]. PLOS ONE,2012,7(3).
APA	Wu, Bin.,Dong, Baijun.,Xu, Yuejuan.,Zhang, Qiang.,Shen, Jinfang.,...&Xue, Wei.(2012).Economic Evaluation of First-Line Treatments for Metastatic Renal Cell Carcinoma: A Cost-Effectiveness Analysis in A Health Resource-Limited Setting.PLOS ONE,7(3).
MLA	Wu, Bin,et al."Economic Evaluation of First-Line Treatments for Metastatic Renal Cell Carcinoma: A Cost-Effectiveness Analysis in A Health Resource-Limited Setting".PLOS ONE 7.3(2012).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。